Measles is endemic again in the U.S. after a transmission chain lasted more than 12 months. Doctors say rebuilding vaccination coverage will take years.

The loss of U.S. measles elimination status marks a shift in how the country must manage the disease: measles is now circulating through a sustained chain of transmission, rather than arriving only through travel-related cases. The designation had stood for 26 years, but an independent expert commission advising the Pan American Health Organization (PAHO) concluded that endemic transmission had returned in the United States, Bolivia, and Mexico.
PAHO Director Jarbas Barbosa accepted the commission’s recommendation to withdraw the three countries’ status. “The current situation requires urgent attention,” he said at a media briefing. The decision follows a sharp rise in U.S. cases: 5,412 were officially reported in 2026, the highest annual total in more than 30 years.
What the status measures
Measles elimination doesn’t mean a country has no cases. As infectious disease specialist Amesh A. Adalja of the Johns Hopkins Center for Health Security explains, imported cases can still trigger outbreaks in a country that has eliminated the disease. The distinction is that those outbreaks end within a year because enough people are immune to stop ongoing spread.
PAHO’s independent experts assess transmission data, including viral genetic sequences. Those sequences help determine whether cases belong to one continuous chain or stem from separate introductions. The U.S. lost its status because a single chain continued for at least 12 months, which meets the definition of endemic transmission.
Thomas Russo, professor and chief of infectious disease at the University at Buffalo, describes the review as fact based and nonpolitical. The designation therefore reflects how measles is spreading, rather than simply the number of cases recorded in a given year.
More routine exposure, greater risk
With sustained spread established, doctors expect measles exposure to become more common in places such as schools, airports, and emergency rooms. Adalja warns that more exposure can mean more children kept out of class and more hospitalizations. The impact is likely to fall hardest on infants who are too young for their first measles, mumps, and rubella (MMR) vaccine dose, as well as people with weakened immune systems who depend on broad community immunity.
Measles can cause severe illness. According to the CDC, about one in five unvaccinated people who contract measles in the U.S. is hospitalized. Among children who get the disease, one to three in every 1,000 die. Pneumonia affects about one in 20 children with measles and is the most common cause of measles-related death in children; roughly one in 1,000 develops brain swelling that can lead to deafness or intellectual disability.
The disease can also cause pregnancy complications and immune amnesia, a loss of immune system memory that can leave people more vulnerable to infections their bodies had previously fought off. Those consequences make sustained circulation a concern beyond the immediate number of cases.
Infectious disease specialist William Schaffner, a professor at Vanderbilt University School of Medicine, sees the U.S. reversal as a setback with potential consequences beyond its borders. The country had demonstrated that measles could be eliminated nationally. Its return, he worries, could weaken other countries’ resolve to devote resources to measles control.
Coverage gaps are the central challenge
Rebuilding protection will require higher MMR vaccination coverage across communities, not just a stronger national average. Adalja says two-dose coverage needs to rise above 95% in every community. Kindergarten coverage has fallen to about 92%, and that figure can conceal local areas with much lower coverage—places where the virus can spread more easily.
States set school vaccination requirements, and Adalja says reducing nonmedical exemptions is part of the response. Earlier elimination efforts concentrated on children; restoring elimination will require attention to both children and adults. Repeated false claims about MMR vaccine safety also contribute to hesitation, he says.
Schaffner argues that pediatricians, family doctors, health departments, and national leaders need to communicate clearly and consistently about vaccination. Confusing messages, he says, have contributed to skepticism among parents. Schools have a role, too: teaching students how vaccines work and which diseases they prevent can prepare them to make informed health decisions as adults and future parents.
Recovery will take years
There is a path back to elimination, but the clock cannot start while sustained transmission continues. The U.S. will need to go at least 12 months without a continuous chain of measles transmission. Adalja points to Brazil, which lost and later regained its elimination status; that recovery took about five years.
Vaccination reduces risk substantially, though it doesn’t make infection impossible. Russo says the MMR vaccine is close to perfect but not perfect; vaccinated people who do contract measles generally have a less severe illness. As the number of cases rises, however, even vaccinated people face more opportunities for exposure.
The practical test now is whether communities can close the coverage gaps that allow measles to keep spreading. Until transmission stops, the U.S. remains outside the elimination standard—and the recovery period cannot begin.
Discussion
Sign in to join the discussion.